Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic effect of melatonin, metformin and vitamin E in non-alcoholic fatty liver disease
IRCT2016040318124N3Phase 3Completed
- Sponsor
- Qazvin University of Medical Sciences
- Start
- Dec 2015
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of melatonin, metformin and vitamin e in metabolic dysfunction-associated steatotic liver disease (MASLD), sponsored by Qazvin University of Medical Sciences. Started Dec 2015; status: completed.
02
Drugs
melatoninmetforminvitamin e
03
Conditions
metabolic dysfunction-associated steatotic liver disease (MASLD)
Beyond the preview
Go deeper on IRCT2016040318124N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016040318124N3.